{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:49:24Z","timestamp":1792367364995,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004935","name":"Suleyman Demirel University","doi-asserted-by":"publisher","award":["TSG-2024-9268"],"award-info":[{"award-number":["TSG-2024-9268"]}],"id":[{"id":"10.13039\/501100004935","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177913","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:36:38Z","timestamp":1751430998000},"page":"177913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Dapagliflozin mitigates lipopolysaccharide-induced neuroinflammation through potential involvement of the IL-17A\/GSK3\u03b2 signaling pathway and modulation of inflammatory cytokines"],"prefix":"10.1016","volume":"1003","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3850-0137","authenticated-orcid":false,"given":"O.","family":"Imeci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Asci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Asci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Sevuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.S.","family":"Sarikaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177913_bib1","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.2389-21.2022","article-title":"Oxidative stress-induced damage to the developing hippocampus is mediated by GSK3\u03b2","volume":"42","author":"Abbah","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177913_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112628","article-title":"The dynamic interplay between AMPK\/NF\u03baB signaling and NLRP3 is a new therapeutic target in inflammation: emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury","volume":"147","author":"Abd El-Fattah","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177913_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/acschemneuro.0c00722","article-title":"Targeting ROS-dependent AKT\/GSK-3\u03b2\/NF-\u03baB and DJ-1\/Nrf2 pathways by dapagliflozin attenuates neuronal injury and motor dysfunction in rotenone-induced parkinson's disease rat model","volume":"12","author":"Arab","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177913_bib4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/10520295.2021.2004616","article-title":"Astaxanthin ameliorates damage to the cerebral cortex, hippocampus, and cerebellar cortex caused by methotrexate","volume":"97","author":"Aslankoc","year":"2022","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.ejphar.2025.177913_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.156057","article-title":"Stabilization of E-cadherin adhesions by COX-2\/GSK3\u03b2 signaling is a targetable pathway in metastatic breast cancer","volume":"8","author":"Balamurugan","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2025.177913_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2025.177913_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.566922","article-title":"Interleukin-17A: the key cytokine in neurodegenerative diseases","volume":"12","author":"Chen","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2025.177913_bib8","article-title":"The role and mechanism of dapagliflozin in Alzheimer's disease: a review","volume":"103","author":"Chen","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.ejphar.2025.177913_bib9","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1038\/onc.2014.286","article-title":"Th17-type cytokines, IL-6 and TNF-\u03b1, synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth","volume":"34","author":"De Simone","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2025.177913_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101285","article-title":"The diuretic effects of SGLT2 inhibitors: a comprehensive review of their specificities and their role in renal protection","volume":"47","author":"Delanaye","year":"2021","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ejphar.2025.177913_bib11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40265-019-01148-3","article-title":"Dapagliflozin: a review in type 2 diabetes","volume":"79","author":"Dhillon","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2025.177913_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118076","article-title":"Dapagliflozin improves behavioral dysfunction of Huntington's disease in rats by inhibiting apoptosis-related glycolysis","volume":"257","author":"El-Sahar","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.177913_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12883-018-1086-4","article-title":"Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy","volume":"18","author":"Erdogan","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ejphar.2025.177913_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/1440-1681.13638","article-title":"Dapagliflozin attenuates high glucose\u2010induced endothelial cell apoptosis and inflammation through AMPK\/SIRT1 activation","volume":"49","author":"Faridvand","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2025.177913_bib15","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1038\/s41467-022-30409-1","article-title":"TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3\u03b2\/\u03b2-catenin signalling","volume":"13","author":"Gao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177913_bib16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/bph.15984","article-title":"Characterization of immune checkpoint inhibitor\u2010induced cardiotoxicity reveals interleukin\u201017A as a driver of cardiac dysfunction after anti\u2010PD\u20101 treatment","volume":"180","author":"Gergely","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177913_bib17","doi-asserted-by":"crossref","first-page":"9424","DOI":"10.18632\/aging.102394","article-title":"Neuroprotective effects of protocatechuic aldehyde through PLK2\/p-GSK3\u03b2\/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson\u2019s disease","volume":"11","author":"Guo","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.ejphar.2025.177913_bib18","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.3390\/molecules27196190","article-title":"Development of UPLC-MS\/MS method to study the pharmacokinetic interaction between sorafenib and Dapagliflozin in rats","volume":"27","author":"He","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177913_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710146","article-title":"Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation","volume":"23","author":"Hsieh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177913_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02527","article-title":"Polydatin prevents lipopolysaccharide (LPS)-induced parkinson\u2019s disease via regulation of the AKT\/GSK3\u03b2-Nrf2\/NF-\u03baB signaling axis","volume":"9","author":"Huang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177913_bib21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jcmgh.2022.02.009","article-title":"Hepatic TGF\u03b2r1 deficiency attenuates Lipopolysaccharide\/D-Galactosamine\u2013Induced acute liver failure through inhibiting GSK3\u03b2\u2013Nrf2\u2013Mediated hepatocyte apoptosis and ferroptosis","volume":"13","author":"Huang","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177913_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2021.08.213","article-title":"GSK3\u03b2 is involved in promoting Alzheimer\u2019s disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor proteinNL-F\/NL-F knock-in mice","volume":"98","author":"Jiang","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2025.177913_bib23","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/antiox11112167","article-title":"The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives","volume":"11","author":"Jurc\u0103u","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2025.177913_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118798","article-title":"GSK3 modulation in acute lung injury, myocarditis, and polycystic kidney disease-related aneurysm","volume":"1867","author":"Liu","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2025.177913_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2025.177913_bib26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1208\/s12248-011-9297-2","article-title":"Pharmacodynamic model of sodium\u2013glucose transporter 2 (SGLT2) inhibition: implications for quantitative translational pharmacology","volume":"13","author":"Maurer","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2025.177913_bib27","article-title":"Corrigendum: the paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases","volume":"14","author":"Navarro-Comp\u00e1n","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177913_bib28","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2147\/DMSO.S258593","article-title":"Dapagliflozin activates neurons in the central nervous system and regulates cardiovascular activity by inhibiting SGLT-2 in mice&lt","volume":"13","author":"Nguyen","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.ejphar.2025.177913_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70071","article-title":"Remifentanil ameliorates lipopolysaccharide-induced neuroinflammation by regulating the phosphatidylinositol 3-Kinase\/Serine\u2013Threonine protein Kinase\/Hypoxia-inducible factor 1 alpha pathway","volume":"13","author":"\u00d6zcan","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ejphar.2025.177913_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/08923973.2021.2025246","article-title":"Dexpanthenol may protect the brain against lipopolysaccharide induced neuroinflammation via anti-oxidant action and regulating CREB\/BDNF signaling","volume":"44","author":"Ozdamar Unal","year":"2022","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ejphar.2025.177913_bib31","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.3390\/molecules26237213","article-title":"Neuroprotective effect of SGLT2 inhibitors","volume":"26","author":"Pawlos","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177913_bib32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/ph16050753","article-title":"Dapagliflozin ameliorates cognitive impairment in aluminum-chloride-induced Alzheimer\u2019s disease via modulation of AMPK\/mTOR, oxidative stress and glucose metabolism","volume":"16","author":"Samman","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2025.177913_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2017.08.005","article-title":"SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats","volume":"333","author":"Sa-nguanmoo","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177913_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154957","article-title":"Agomelatine could prevent brain and cerebellum injury against LPS-induced neuroinflammation in rats","volume":"127","author":"Savran","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.ejphar.2025.177913_bib35","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s10753-019-01053-7","article-title":"The impact of prophylactic lacosamide on LPS-induced neuroinflammation in aged rats","volume":"42","author":"Savran","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.ejphar.2025.177913_bib36","article-title":"Th17 cells and inflammation in neurological disorders: possible mechanisms of action","volume":"13","author":"Shi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.177913_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0025-7753(17)30624-3","article-title":"Implicaciones hemodin\u00e1micas y renales de los inhibidores del cotransportador sodio-glucosa tipo 2 en el contexto de la diabetes mellitus tipo 2","volume":"147","author":"Tejedor Jorge","year":"2016","journal-title":"Med. Clin."},{"key":"10.1016\/j.ejphar.2025.177913_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127375","article-title":"A review of glycogen synthase Kinase-3 (GSK3) inhibitors for cancers therapies","volume":"253","author":"Thapa","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejphar.2025.177913_bib39","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/cells11081312","article-title":"Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs","volume":"11","author":"Twarda-Clapa","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2025.177913_bib40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.14744\/AnatolJCardiol.2023.2825","article-title":"Dapagliflozin may protect against doxorubicin-induced cardiotoxicity","author":"Ulusan","year":"2023","journal-title":"Anatol. J. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177913_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108832","article-title":"Methylglyoxal induces death in human brain neuronal cells (SH-SY5Y), prevented by metformin and dapagliflozin","volume":"38","author":"Victor-Sami","year":"2024","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.ejphar.2025.177913_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/npr2.12351","article-title":"Possible involvement of <scp>Interleukin\u201017A<\/scp> in the deterioration of prepulse inhibition on acoustic startle response in mice","volume":"43","author":"Wakabayashi","year":"2023","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.ejphar.2025.177913_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12974-022-02438-6","article-title":"Irisin ameliorates neuroinflammation and neuronal apoptosis through integrin \u03b1V\u03b25\/AMPK signaling pathway after intracerebral hemorrhage in mice","volume":"19","author":"Wang","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2025.177913_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113572","article-title":"Dexmedetomidine attenuates myocardial ischemia\/reperfusion-induced ferroptosis via AMPK\/GSK-3\u03b2\/Nrf2 axis","volume":"154","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177913_bib45","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2147\/JIR.S300806","article-title":"Activation of GSK3 prevents termination of TNF-induced signaling","volume":"14","author":"Welz","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejphar.2025.177913_bib46","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3892\/or.2017.5721","article-title":"Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK\/p-Ser9-GSK-3\u03b2\/p-Tyr216-GSK-3\u03b2\/\u03b2-catenin axis","volume":"38","author":"Xu","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2025.177913_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115213","article-title":"Dapagliflozin prevents oxidative stress-induced endothelial dysfunction via sirtuin 1 activation","volume":"165","author":"Zhou","year":"2023","journal-title":"Biomed. Pharmacother."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:32:46Z","timestamp":1762144366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925006673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":47,"alternative-id":["S0014299925006673"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177913","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin mitigates lipopolysaccharide-induced neuroinflammation through potential involvement of the IL-17A\/GSK3\u03b2 signaling pathway and modulation of inflammatory cytokines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177913"}}